SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001193125-12-430319
Filing Date
2012-10-22
Accepted
2012-10-22 17:29:47
Documents
7

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d426856d8k.htm 425 52415
2 MERGER AGREEMENT d426856dex21.htm EX-2.1 574282
3 INVESTOR FINANCING AGREEMENT d426856dex22.htm EX-2.2 182607
4 VOTING AND POST-CLOSING LOCK-UP AGREEMENT d426856dex23.htm EX-2.3 145565
5 SIDE AGREEMENT TO INVESTOR FINANCING AGREEMENT d426856dex24.htm EX-2.4 114241
6 TRANSCRIPT OF CONFERENCE CALL d426856dex991.htm EX-99.1 135451
7 GRAPHIC g426856thomson_logo.jpg GRAPHIC 6723
  Complete submission text file 0001193125-12-430319.txt   1215525
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filed by) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Subject) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 000-23186 | Film No.: 121155243
SIC: 2836 Biological Products, (No Diagnostic Substances)